Yahoo
SAN DIEGO, March 31, 2025 (GLOBE NEWSWIRE) -- Gyre Therapeutics (“Gyre”) (Nasdaq: GYRE), an innovative, commercial-stage biotechnology company focused on organ fibrosis, today announced that the National Medical Products Administration (NMPA) of the People’s Republic of China (“PRC”) has approved its clinical trial application for a potential new indication for pirfenidone in oncology-related pulmonary complications. The trial will evaluate pirfenidone capsules for the treatment of radiation-ind
Yahoo
The stock price didn't jump after Gyre Therapeutics, Inc. ( NASDAQ:GYRE ) posted decent earnings last week. We did some...
Yahoo
SAN DIEGO, March 27, 2025 (GLOBE NEWSWIRE) -- Gyre Therapeutics (“Gyre”) (Nasdaq: GYRE), an innovative, commercial-stage biotechnology company with clinical development programs focusing on organ fibrosis, today announced the publication of the manuscript titled “Hydronidone for the Treatment of Liver Fibrosis Associated with Chronic Hepatitis B: Protocol for a Phase 3 Randomized Trial” in the Journal of Clinical and Translational Hepatology. This publication details the full protocol for the pi
SeekingAlpha
Discover why Gyre Therapeutics is rated 'Hold' amid volatile stock behavior, uncertain long-term prospects, and pending Phase 3 data for its liver fibrosis...
Yahoo
Gyre Therapeutics ( NASDAQ:GYRE ) Full Year 2024 Results Key Financial Results Revenue: US$105.8m (down 6.8% from FY...
Yahoo
Data from pivotal Phase 3 trial in CHB-associated liver fibrosis expected in Q2 2025 Commercial launch in the PRC of generic nintedanib for the treatment of IPF and avatrombopag maleate tablets for the treatment of CLD-associated thrombocytopenia expected in 2025 Initiation of U.S. Phase 2 trial of F351 in MASH-associated liver fibrosis expected in 2025 Full year 2025 total revenue guidance of $118 to $128 million SAN DIEGO, March 17, 2025 (GLOBE NEWSWIRE) -- Gyre Therapeutics (“Gyre”) (Nasdaq:
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
CWCO | 37.72% | $387.98M | -6.75% | 1.74% |
ACA | 36.92% | $3.81B | -5.98% | 0.26% |
RYTM | 36.01% | $3.16B | +24.84% | 0.00% |
KYMR | 34.59% | $1.64B | -32.96% | 0.00% |
BEAM | 33.85% | $1.76B | -42.28% | 0.00% |
SFBS | 33.62% | $4.42B | +29.14% | 1.59% |
RCKT | 33.29% | $619.52M | -77.39% | 0.00% |
DNLI | 33.28% | $1.78B | -36.58% | 0.00% |
URI | 32.87% | $41.29B | -8.64% | 1.08% |
SEM | 32.53% | $2.13B | +4.82% | 2.69% |
CRBU | 32.44% | $78.23M | -82.40% | 0.00% |
EVER | 32.35% | $948.83M | +43.34% | 0.00% |
CRH | 32.20% | $60.22B | +5.28% | 0.42% |
PFS | 32.13% | $2.12B | +17.18% | 5.64% |
KN | 32.11% | $1.33B | -5.90% | 0.00% |
VRDN | 32.03% | $1.02B | -24.75% | 0.00% |
PNFP | 31.97% | $8.10B | +27.81% | 0.87% |
PIPR | 31.82% | $4.46B | +29.99% | 1.03% |
LPRO | 31.69% | $139.64M | -79.51% | 0.00% |
KODK | 31.64% | $498.91M | +27.89% | 0.00% |
Current Value
$8.221 Year Return
Current Value
$8.221 Year Return
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
CPRJ | 53.66% | $48.36M | 0.69% |
RSPA | 46.84% | $292.30M | 0% |
QQA | 40.47% | $172.76M | 0% |
CPSJ | 40.16% | $32.86M | 0.69% |
IWC | 38.63% | $799.66M | 0.6% |
ETH | 38.35% | $1.29B | 0% |
QETH | 38.33% | $13.73M | 0.25% |
ETHW | 38.05% | $174.65M | 0% |
EZET | 38.04% | $21.63M | 0% |
FETH | 38.04% | $733.92M | 0.25% |
CETH | 38.04% | $8.44M | 0% |
ETHA | 37.95% | $2.19B | 0.25% |
ETHV | 37.90% | $84.73M | 0% |
XBI | 36.97% | $5.07B | 0.35% |
IWM | 36.50% | $63.34B | 0.19% |
VTWO | 36.44% | $10.85B | 0.07% |
BTC | 36.44% | $3.28B | 0.15% |
IWO | 35.93% | $10.75B | 0.24% |
IWN | 35.91% | $10.95B | 0.24% |
GSSC | 35.62% | $513.14M | 0.2% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
SPTL | -0.02% | $11.73B | 0.03% |
CGCB | 0.03% | $1.99B | 0.27% |
UNG | 0.04% | $420.93M | 1.06% |
FXY | -0.07% | $548.86M | 0.4% |
CORN | -0.08% | $51.42M | 0.2% |
IBD | 0.08% | $381.57M | 0.44% |
EDV | -0.09% | $3.99B | 0.05% |
BILZ | 0.12% | $691.33M | 0.14% |
TLT | 0.14% | $51.85B | 0.15% |
SCHO | -0.17% | $10.67B | 0.03% |
TBIL | 0.18% | $5.35B | 0.15% |
IBTM | 0.21% | $308.85M | 0.07% |
UTWO | 0.23% | $377.49M | 0.15% |
VGLT | 0.27% | $9.96B | 0.03% |
DUSB | 0.32% | $1.15B | 0.15% |
VGSH | 0.34% | $22.45B | 0.03% |
ICSH | 0.35% | $5.66B | 0.08% |
SHYD | 0.38% | $320.31M | 0.35% |
ZROZ | -0.39% | $1.60B | 0.15% |
MUB | 0.44% | $39.52B | 0.05% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
VIXY | -24.98% | $195.31M | 0.85% |
BTAL | -24.79% | $414.68M | 1.43% |
TAIL | -23.88% | $86.59M | 0.59% |
CLOI | -10.62% | $1.02B | 0.4% |
TBLL | -9.88% | $2.07B | 0.08% |
XONE | -8.76% | $633.49M | 0.03% |
PWZ | -8.68% | $700.01M | 0.28% |
XBIL | -8.49% | $708.50M | 0.15% |
CTA | -8.01% | $964.37M | 0.76% |
TPMN | -7.95% | $33.32M | 0.65% |
JMST | -7.61% | $3.55B | 0.18% |
ULST | -7.59% | $587.14M | 0.2% |
DFNM | -6.39% | $1.51B | 0.17% |
IBTP | -6.14% | $109.02M | 0.07% |
TUR | -4.86% | $184.96M | 0.59% |
UUP | -4.79% | $325.55M | 0.77% |
TAXF | -4.75% | $516.85M | 0.29% |
SHM | -4.44% | $3.42B | 0.2% |
TOTL | -4.40% | $3.51B | 0.55% |
CGSM | -4.39% | $639.13M | 0.25% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
CBOE | -16.30% | $23.56B | +23.21% | 1.08% |
LITB | -15.00% | $41.37M | -43.18% | 0.00% |
CYCN | -10.42% | $6.88M | -19.62% | 0.00% |
GL | -9.98% | $11.00B | +18.35% | 0.73% |
GIS | -9.67% | $32.70B | -15.36% | 3.98% |
NEUE | -9.04% | $57.12M | +3.45% | 0.00% |
SYPR | -9.02% | $37.98M | 0.00% | 0.00% |
SYY | -8.86% | $36.90B | -6.23% | 2.69% |
SRDX | -8.84% | $441.60M | +14.53% | 0.00% |
WTW | -8.80% | $33.60B | +25.84% | 1.06% |
INSM | -8.66% | $13.03B | +173.76% | 0.00% |
CORT | -8.40% | $9.70B | +262.50% | 0.00% |
EZPW | -8.31% | $852.65M | +42.25% | 0.00% |
TEF | -8.29% | $26.52B | +7.31% | 6.69% |
VRSK | -7.55% | $41.89B | +28.72% | 0.54% |
GHI | -7.43% | $282.69M | -23.75% | 12.19% |
MRK | -7.29% | $220.07B | -33.16% | 3.63% |
CNC | -7.23% | $29.99B | -16.56% | 0.00% |
PG | -6.65% | $399.94B | +6.22% | 2.36% |
FUBO | -6.60% | $1.01B | +92.21% | 0.00% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
NYT | 0.03% | $8.20B | +16.38% | 1.41% |
ZCMD | 0.06% | $31.27M | -1.59% | 0.00% |
THS | -0.08% | $1.35B | -28.43% | 0.00% |
BG | -0.08% | $10.43B | -25.07% | 3.50% |
CYD | 0.11% | $723.60M | +110.58% | 2.15% |
MKTX | 0.15% | $8.14B | +0.73% | 1.39% |
ACGL | -0.16% | $36.12B | +10.51% | 0.00% |
OCFT | 0.22% | $248.36M | +209.63% | 0.00% |
DUK | 0.24% | $94.07B | +25.41% | 3.43% |
NEXA | 0.25% | $814.50M | -15.41% | 0.00% |
MX | -0.30% | $127.99M | -36.79% | 0.00% |
MVO | 0.32% | $63.94M | -50.31% | 23.82% |
D | 0.34% | $47.94B | +15.48% | 4.74% |
HRZN | -0.34% | - | - | 13.94% |
OXSQ | 0.34% | - | - | 16.22% |
FTS | 0.35% | $23.03B | +17.09% | 3.76% |
UAA | 0.36% | $2.73B | -10.31% | 0.00% |
CLX | 0.37% | $18.22B | -0.54% | 3.28% |
LTM | -0.38% | $9.40B | -100.00% | <0.01% |
FMS | 0.40% | $14.52B | +31.81% | 2.66% |